Use of serum CA 125 measurement in posttreatment surveillance of early-stage endometrial carcinoma
- 1 February 1990
- journal article
- research article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 162 (2) , 427-429
- https://doi.org/10.1016/0002-9378(90)90400-2
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Predictive value of preoperative serum CA 125 levels in clinically localized and advanced endometrial carcinomaAmerican Journal of Obstetrics and Gynecology, 1988
- CA 125: A useful marker in endometrial carcinomaAmerican Journal of Obstetrics and Gynecology, 1986
- The CA 125 assay as a predictor of clinical recurrence in epithelial ovarian cancerAmerican Journal of Obstetrics and Gynecology, 1986
- Elevation of serum CA125 in carcinomas of the fallopian tube, endometrium, and endocervixAmerican Journal of Obstetrics and Gynecology, 1984
- MONOCLONAL-ANTIBODY IMMUNORADIOMETRIC ASSAY FOR AN ANTIGENIC DETERMINANT (CA 125) ASSOCIATED WITH HUMAN EPITHELIAL OVARIAN CARCINOMAS1984